The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...
OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...
The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming ...
The deal replaces a previous, $6 billion agreement that was rejected last July by the Supreme Court because it would have ...
Utah will receive $57 million to combat the state’s opioid crisis if it joins the $7.4 billion settlement against the Sackler ...
A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack.
The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was ...
This story incorporates reporting fromBoston.com, Philadelphia Inquirer, The Boston Globe, pharmaphorum, Hartford Courant, ...
Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...